Retrotope, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.retrotope.com
RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04937530
- Locations
- ๐ฉ๐ช
Agaharied Teaching Hospital, University of Munich, Munich, MD, Germany
RT001 in Amyotrophic Lateral Sclerosis
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04762589
- Locations
- ๐ณ๐ฑ
UMC Utrecht, Utrecht, Netherlands
๐ฑ๐ปRiga Stradins Universtiy, Riga, Latvia
๐ธ๐ชKarolinska, Stockholm, Sweden
A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04102501
- Locations
- ๐บ๐ธ
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
๐บ๐ธCollaborative Neuroscience Network, LLC, Long Beach, California, United States
๐บ๐ธUniversity of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States
A Natural History Study of Infantile Neuroaxonal Dystrophy
- Conditions
- Neuroaxonal Dystrophy, Infantile
- First Posted Date
- 2019-07-22
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT04027816
- Locations
- ๐จ๐ณ
Peking University First Hospital, Beijing, China
๐ช๐ฌNational Research Centre, Cairo, Egypt
๐ธ๐ฆKing Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Natural History of Infantile Neuroaxonal Dystrophy
- Conditions
- INADInfantile Neuroaxonal Dystrophy
- First Posted Date
- 2019-06-27
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT03999814
- Locations
- ๐บ๐ธ
Sarah Endemann, Los Altos, California, United States
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03570931
- Locations
- ๐บ๐ธ
Jacobs Levy Genomics and Research Program, Morristown, New Jersey, United States
๐บ๐ธUniversity of California San Francisco, Benioff Children's Hospital, San Francisco, California, United States
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
- Conditions
- Friedreich's Ataxia
- Interventions
- Drug: Low dose cohortDrug: High dose cohort
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT02445794
- Locations
- ๐บ๐ธ
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
๐บ๐ธUniversity of South Florida, Tampa, Florida, United States